M&A

Biopharma dealmaking continues to rise, but M&A values hold steady: PwC
Fierce Biotech
Thu, 06/20/24 - 11:43 am
M&A
PwC
Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount
Fierce Pharma
Thu, 06/20/24 - 11:42 am
Vanda Pharmaceuticals
M&A
CDMOs
Future Pak
Cycle Pharmaceuticals
Boston Scientific Weaves a $1.16B Acquisition
Medical Devices and Diagnostics Industry
Tue, 06/18/24 - 07:54 pm
Boston Scientific
Medtech
M&A
Silk Road Medical
TCAR
Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market
BioSpace
Wed, 06/12/24 - 11:09 am
Biogen
Hi-Bio
M&A
After M&A stretch, Pfizer CEO says company needs 'breathing period' from large deals
Fierce Pharma
Tue, 06/11/24 - 11:41 am
Pfizer
Albert Bourla
Pharma CEOs
M&A
As biotech recovers, venture firms’ preferences appear to shift
BioPharma Dive
Fri, 06/7/24 - 11:26 am
funding
biotech
venture capital
M&A
IPOs
GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M
Fierce Biotech
Thu, 06/6/24 - 11:51 am
GSK
Elsie Biotechnologies
M&A
oligonucleotides
Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma
Fierce Pharma
Thu, 06/6/24 - 11:30 am
Vanda Pharmaceuticals
JNJ
M&A
Cycle Pharma
Future Pak
Fanapt
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
M&A
Vertex Pharmaceuticals
Regeneron
Biogen
Moderna Therapeutics
Edwards to sell critical care products unit to Becton Dickinson for $4.2 bln
Reuters
Mon, 06/3/24 - 11:59 am
Medtech
M&A
Edwards Lifesciences
Becton Dickinson
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
M&A
Merck
EyeBio
JNJ
Numab Therapeutics
Asahi Kasei
Calliditas Therapeutics
Digital therapeutics firm Akili to sell for $34M
Medtech Dive
Thu, 05/30/24 - 11:11 pm
Medtech
M&A
digital therapeutics
ADHD
Akili Interactive
Virtual Therapeutics
FTC request may signal trouble for Novo/Catalent deal
Pharma Voice
Thu, 05/30/24 - 11:09 am
Novo Holdings
Catalent
FTC
M&A
Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics
BioSpace
Tue, 05/28/24 - 10:34 pm
Asahi Kasei
M&A
Calliditas Therapeutics
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive
Thu, 05/23/24 - 09:37 pm
Merck KGaA
M&A
MilliporeSigma
Gamma Biosciences
gene therapy
Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B
Medical Marketing and Media
Wed, 05/22/24 - 11:38 am
Biogen
Human Immunology Biosciences
M&A
Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal
NASDAQ
Fri, 05/17/24 - 11:24 am
Novartis
MorphoSys
M&A
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive
Thu, 05/16/24 - 11:41 am
JNJ
M&A
Proteologix
bispecific antibodies
Biopharma M&A activity jumped 71% in Q1 2024
Medical Marketing and Media
Thu, 05/16/24 - 11:37 am
M&A
Novo Nordisk
Catalent
Gilead Sciences
CymaBay Therapeutics
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx

Pages